Andrew Dahl, founder and chairman of BioMEMS Diagnostics, shared how his business seeks to transform the diagnostics sector, in response to emailed questions. Why did you start this company?

Nanotechnology, VLSI fabrication, genetic engineering and drug design intersect in the rapidly developing field of BioMEMS, a curious blend of organic and inorganic systems that is seeing explosive ...

BioMEMS Diagnostics, a Michigan-based diagnostics developer, has opened an assay development/optimization laboratory on the Gunnison, Colorado campus of Western ...

PORTLAND, Ore. — Widely considered the father of bioMEMS, Professor Mauro Ferrari has founded a company to commercialize MEMS-based medical solutions and possible space applications. NanoMedical ...

BioMEMS devices, defined as MEMS sensors and microfluidic devices integrated into medical devices and used for IVD and life sciences, were a $3.7 billion Market in 2019 and is expected to reach $6.3 ...

Purdue's 2008 Physiological Sensing Symposium, titled "Multiscale Integration of Nanotechnology, BioMEMS and Biology," is planned for Thursday (Nov. 20) in Discovery Park. The event, featuring ...

The frontiers of microtechnology and nanotechnology are changing the face of medicine through the efforts of researchers to build biomedical microelectromechanical systems, or bioMEMS - tiny working ...

Bourne Research has launched The Bourne Report - Medical Device Quarterly, a report series dedicated to covering the use of MEMS and Nanotechnology in medicine. Geared toward physicians, life science ...